TABLE 8.

Visual acuity outcomes after 2 months of adapted wear time for each prescription type.

Viewing condition	Treatment	Estimate (logMAR)	95% CI
Binocular visual acuity	PFSt	0.31	0.26–0.36
	VSX	0.33	0.27–0.38
	Clinical	0.34	0.28–0.39
Monocular visual acuity	PFSt	0.41	0.35–0.46
	VSX	0.37	0.31–0.42
	Clinical	0.41	0.35–0.47

Note: PFSt is the refraction determined from optimisation of the metric pupil fraction for slope tessellation. VSX is the refraction determined from optimisation of the metric visual Strehl in space domain. CI is the 95% confidence interval. Data from Anderson et al.61